Future of research-based pharma industry
Though large drug companies have designed themselves around the promotion of blockbuster products for widespread ailments, many of those products are losing patent protection and being replaced by cheap generics, says Dr Krishan Maggon

Living on the edge
Trade agreements could be designed to benefit the participants provided the negotiating country remains fully engaged and committed, says Jayashree Padmini